跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73 条关于
“Reshma Kewalramani”
全部
73
临床试验
39
药物
2
机构
3
资讯
29
上个月
Vertex CEO Reshma Kewalramani Leads CRISPR Revolution as Pharma's Top Women Executives Reshape the Industry
去年
Vertex Pharmaceuticals Discontinues VX-993 Development After Phase 2 Failure in Acute Pain
去年
FDA Approves Casgevy for Beta Thalassemia, Marking Second Indication for First CRISPR-Based Therapy
去年
Vertex Pharmaceuticals Launches JOURNAVX, First Non-Opioid Acute Pain Treatment in Over Two Decades
去年
Vertex COO Stuart Arbuckle to Retire; Company Announces Key Leadership Changes
去年
Vertex Pharmaceuticals Reports Strong Q1 2025 Results with 8% Revenue Growth Projection Amid Pipeline Advancements
去年
Vertex Raises 2024 Revenue Guidance Amidst Promising Pipeline Advancements
去年
Vertex and Sernova Advance Functional Cures for Type 1 Diabetes
去年
Eli Lilly CEO David Ricks Tops Pharma Executive Compensation at $29.2 Million in 2024
去年
Vertex and Ono Pharmaceutical Form Strategic Alliance for Povetacicept Development in Japan and South Korea
第 1 页,共 3 页
上一页
下一页